Nootropics Index - Save on smarter supplements
Vitamins & vitamin-like compounds

Adenosylcobalamin

Adenosylcobalamin (adenosylated cobalamin coenzyme form)

Adenosylcobalamin is a coenzyme form of vitamin B12 also called cobamamide or dibencozide; for a useful product comparison, compare dose, route, stability, and quality documentation rather than choosing solely on “active B12” marketing.

Water SolubleClinical ResearchForm Dependent EvidenceLow Risk Profile
Updated August 2026/4 min read/2 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

Identity and form

1

Adenosylcobalamin is a coenzyme form of vitamin B12 also called cobamamide or dibencozide.

02

Names, aliases and forms

Common NamesCobamamide; Dibencozide
03

Mechanisms of action

Biological role

1

It serves as the cofactor for methylmalonyl-CoA mutase.

04

Potential effects and evidence map

Evidence is strong for the essential nutrient role of vitamin B12, but supplementation beyond adequacy has not been shown to produce a reliable general nootropic effect in well-nourished adults. Form-specific clinical uses should be evaluated separately.

Effect domainMagnitudeGrade
Mental energy / wakefulness1
UnknownConfidence: Medium

Evidence does not establish a reliable mental-energy effect from extra Adenosylcobalamin in well-nourished healthy adults.

Note Essential nutrient biology and correction of inadequate status are different from enhancement.

1/5
C
Memory / learning1
UnknownConfidence: Medium

Direct evidence does not establish a general memory or learning benefit from Adenosylcobalamin for healthy adults.

Note Keep form- and population-specific clinical research separate.

0/5
C
05

Typical dosages and timing

Nutrition benchmark12.4 mcg/day

Use this to interpret labels and total intake, not as a demonstrated nootropic dose or recommended cycle.

06

Timing & effect horizon

Effect horizonUnknown
Unknown
What timing evidence can show1

No reliable acute nootropic onset, duration, The time for blood levels to fall by half during the final elimination phase.Source claim, or routine cycle is established for Adenosylcobalamin. Nutrient-status correction and clinical follow-up periods answer different questions.

07

Safety, side effects and risk profile

Evidence uncertainty1
Confidence: High

Marketing claims extend beyond the established nutrient or precursor evidence.

Note Separate adequacy, biochemical activity, and enhancement outcomes.

1/5
B
Interaction risk1
Confidence: Medium

Medication, laboratory, and total-intake context can change the practical risk.

Note Check the official source for ingredient-specific interaction details.

1/5
B
GI discomfort1
Confidence: Medium

Tolerability varies with the specific form and amount consumed.

Note This row summarizes ordinary tolerability rather than special-population hazards.

1/5
B
Dose- and form-specific safety1

Vitamin B12 has low toxicity potential and no established UL; product identity and measured amount should be clear.

08

Interactions and cautions

Medication and test context1

Metformin and gastric-acid inhibitors can reduce B12 status or absorption.

09

Practical buying and quality notes

  • Compare dose, route, stability, and quality documentation rather than choosing solely on “active B12” marketing.1
10

FAQ

What distinguishes Adenosylcobalamin from related forms?

1

Coenzyme-form chemistry does not establish superior absorption or cognitive outcomes for every user.

11

References

  1. NIH Office of Dietary Supplements. Vitamin B12 Fact Sheet for Health Professionals.
  2. PubChem. Cobamamide (Dibencozide) compound record.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.